V
Verónica Ruiz-Torres
Researcher at Institute of Business & Medical Careers
Publications - 11
Citations - 491
Verónica Ruiz-Torres is an academic researcher from Institute of Business & Medical Careers. The author has contributed to research in topics: DNA damage & Silibinin. The author has an hindex of 7, co-authored 11 publications receiving 345 citations. Previous affiliations of Verónica Ruiz-Torres include Universidad Miguel Hernández de Elche.
Papers
More filters
Journal ArticleDOI
An Updated Review on Marine Anticancer Compounds: The Use of Virtual Screening for the Discovery of Small-Molecule Cancer Drugs
Verónica Ruiz-Torres,José Antonio Encinar,María Herranz-López,Almudena Pérez-Sánchez,Vicente Galiano,Enrique Barrajón-Catalán,Vicente Micol,Vicente Micol +7 more
TL;DR: This review gives an overview of MNPs, both in research or clinical stages, from diverse organisms that were reported as being active or potentially active in cancer treatment in the past seventeen years and describes their putative mechanisms of action.
Journal ArticleDOI
Use of advanced techniques for the extraction of phenolic compounds from Tunisian olive leaves: phenolic composition and cytotoxicity against human breast cancer cells.
Amani Taamalli,David Arráez-Román,Enrique Barrajón-Catalán,Verónica Ruiz-Torres,Almudena Pérez-Sánchez,Miguel Herrero,Elena Ibáñez,Vicente Micol,Mokhtar Zarrouk,Antonio Segura-Carretero,Alberto Fernández-Gutiérrez +10 more
TL;DR: A multifactorial behavior is proposed for the anticancer activity of olive leaf compounds because best extraction yields do not correlate with highest cytotoxic activity against breast cancer cells, indicating that cytotoxicity is highly dependent on the presence of certain compounds in the extracts.
Journal ArticleDOI
Rosemary (Rosmarinus officinalis) extract causes ROS-induced necrotic cell death and inhibits tumor growth in vivo.
Almudena Pérez-Sánchez,Enrique Barrajón-Catalán,Verónica Ruiz-Torres,Luz Agulló-Chazarra,María Herranz-López,Alberto Valdés,Alejandro Cifuentes,Vicente Micol,Vicente Micol +8 more
TL;DR: Results indicate that targeting colon cancer cells by increasing intracellular ROS and decreasing cell survival mechanisms may suppose a therapeutic option in colon cancer through the combination of rosemary compounds and chemotherapeutic drugs.
Journal ArticleDOI
Antioxidant and Photoprotective Activity of Apigenin and its Potassium Salt Derivative in Human Keratinocytes and Absorption in Caco-2 Cell Monolayers.
Noelia Sánchez-Marzo,Almudena Pérez-Sánchez,Verónica Ruiz-Torres,Adrián Martínez-Tébar,Julián Castillo,María Herranz-López,Enrique Barrajón-Catalán +6 more
TL;DR: Results suggest that both apigenins may be interesting candidates for the development of oral (nutraceutical) and topical photoprotective ingredients against UVA and UVB-induced skin damage, but the increased water solubility of apigenin-K makes it the best candidate for further development.
Journal ArticleDOI
Intestinal Permeability Study of Clinically Relevant Formulations of Silibinin in Caco-2 Cell Monolayers.
Almudena Pérez-Sánchez,Elisabet Cuyàs,Verónica Ruiz-Torres,Luz Agulló-Chazarra,Sara Verdura,Isabel González-Álvarez,Marival Bermejo,Jorge Joven,Vicente Micol,Vicente Micol,Joaquim Bosch-Barrera,Javier A. Menendez +11 more
TL;DR: The Caco-2 cell monolayer model of human intestinal absorption was utilized to evaluate the permeation properties of three different formulations of silibinin and predicted differential mechanisms of transport and blood–brain barrier permeabilities between the silib inin formulations tested.